Morgan Stanley Maintains Overweight on Rollins, Lowers Price Target to $45

Benzinga Newsdesk www.benzinga.com Negative 74.1%

Neg 74.1% Neu 0% Pos 0%

Morgan Stanley analyst Toni Kaplan maintains Rollins (NYSE:ROL) with a Overweight and lowers the price target from $60 to $45.